Letter from Liu and Yang Regarding Article, “Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
In a recent issue in Circulation, the AATAC trial (Ablation vs Amiodarone for Treatment of Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted ICD/CRTD) found that catheter ablation of atrial fibrillation not only reduced the recurrence of atrial fibrillation at long-term follow-up, but also significantly decreased unplanned hospitalization and mortality in patients with heart failure and persistent atrial fibrillation.1 This work is fantastic and vital because it is the first large trial to demonstrate that catheter ablation is superior to …